Court denies bid to halt Medicare drug price talks
The decision preserves the Biden administration’s power to begin haggling with drug companies over the prices of 10 medications.
Today's Liberal News
By Lauren Gardner
Court denies bid to halt Medicare drug price talks
The decision preserves the Biden administration’s power to begin haggling with drug companies over the prices of 10 medications.
Court denies bid to halt Medicare drug price talks
The decision preserves the Biden administration’s power to begin haggling with drug companies over the prices of 10 medications.
Drugmakers, trade groups push back against Medicare drug price negotiations
Here are summaries of the cases and where they stand.
Drugmakers, trade groups push back against Medicare drug price negotiations
Here are summaries of the cases and where they stand.
Drugmakers, trade groups push back against Medicare drug price negotiations
Here are summaries of the cases and where they stand.
Drugmakers, trade groups push back against Medicare drug price negotiations
Here are summaries of the cases and where they stand.
Drugmakers, trade groups push back against Medicare drug price negotiations
Here are summaries of the cases and where they stand.
Drugmakers, trade groups push back against Medicare drug price negotiations
Here are summaries of the cases and where they stand.
Drugmakers, trade groups push back against Medicare drug price negotiations
Here are summaries of the cases and where they stand.
Drugmakers, trade groups push back against Medicare drug price negotiations
Here are summaries of the cases and where they stand.
Drugmakers, trade groups push back against Medicare drug price negotiations
Here are summaries of the cases and where they stand.
Once-favored Covid drugs ineffective on Omicron may be putting millions at risk
While antiviral pills are plentiful and remain an option for some with weak immune systems, they won’t work for everyone — Pfizer’s Paxlovid interacts with many widely prescribed drugs.
Once-favored Covid drugs ineffective on Omicron may be putting millions at risk
While antiviral pills are plentiful and remain an option for some with weak immune systems, they won’t work for everyone — Pfizer’s Paxlovid interacts with many widely prescribed drugs.
Once-favored Covid drugs ineffective on Omicron may be putting millions at risk
While antiviral pills are plentiful and remain an option for some with weak immune systems, they won’t work for everyone — Pfizer’s Paxlovid interacts with many widely prescribed drugs.
House Dems raise issues with ‘atypical’ FDA review process for Alzheimer’s drug
The panels began investigating Aduhelm’s approval and pricing in June 2021, just weeks after it won the FDA’s backing despite questions about the drug’s clinical benefit to patients.
House Dems raise issues with ‘atypical’ FDA review process for Alzheimer’s drug
The panels began investigating Aduhelm’s approval and pricing in June 2021, just weeks after it won the FDA’s backing despite questions about the drug’s clinical benefit to patients.
Once-favored Covid drugs ineffective on Omicron may be putting millions at risk
While antiviral pills are plentiful and remain an option for some with weak immune systems, they won’t work for everyone — Pfizer’s Paxlovid interacts with many widely prescribed drugs.
House Dems raise issues with ‘atypical’ FDA review process for Alzheimer’s drug
The panels began investigating Aduhelm’s approval and pricing in June 2021, just weeks after it won the FDA’s backing despite questions about the drug’s clinical benefit to patients.
House Dems raise issues with ‘atypical’ FDA review process for Alzheimer’s drug
The panels began investigating Aduhelm’s approval and pricing in June 2021, just weeks after it won the FDA’s backing despite questions about the drug’s clinical benefit to patients.
House Dems raise issues with ‘atypical’ FDA review process for Alzheimer’s drug
The panels began investigating Aduhelm’s approval and pricing in June 2021, just weeks after it won the FDA’s backing despite questions about the drug’s clinical benefit to patients.
CDC advisers recommend adding Covid shots to routine immunization schedules for kids, adults
Covid vaccines’ inclusion on the schedules don’t constitute mandates.
CDC advisers recommend adding Covid shots to routine immunization schedules for kids, adults
Covid vaccines’ inclusion on the schedules don’t constitute mandates.
CDC advisers recommend adding Covid shots to routine immunization schedules for kids, adults
Covid vaccines’ inclusion on the schedules don’t constitute mandates.
CDC advisers recommend adding Covid shots to routine immunization schedules for kids, adults
Covid vaccines’ inclusion on the schedules don’t constitute mandates.
CDC advisers recommend adding Covid shots to routine immunization schedules for kids, adults
Covid vaccines’ inclusion on the schedules don’t constitute mandates.
CDC advisers recommend adding Covid shots to routine immunization schedules for kids, adults
Covid vaccines’ inclusion on the schedules don’t constitute mandates.
CDC advisers recommend adding Covid shots to routine immunization schedules for kids, adults
Covid vaccines’ inclusion on the schedules don’t constitute mandates.
CDC advisers recommend adding Covid shots to routine immunization schedules for kids, adults
Covid vaccines’ inclusion on the schedules don’t constitute mandates.
CDC advisers recommend adding Covid shots to routine immunization schedules for kids, adults
Covid vaccines’ inclusion on the schedules don’t constitute mandates.